Trial intelligence / Profile preview

Lixivaptan in Heart Failure Patients With Chronic Hyponatremia

NCT00876876Phase 3Withdrawn

Sponsor
CardioKine
Start
Jul 2009
Primary completion
Aug 2010
Modality
Small Molecules
01

Overview

A Phase 3 trial of lixivaptan in hyponatremia, sponsored by CardioKine. Planned start Jul 2009; status: withdrawn.

02

Drugs

lixivaptan
03

Conditions

hyponatremia

Beyond the preview

Go deeper on NCT00876876.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00876876.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call